If you would like him and his team to help you take steps towards a healthier lifestyle, contact Chicago Weight Loss Clinic to see what resources are available to you and schedule a free consultation
A few small human trials have been conducted, primarily for inflammatory bowel disease
Announced by Novo Nordisk on January 17, 2025, the randomized, double-blinded, parallel-group, placebo-controlled STEP UP trial evaluated the efficacy of semaglutide 7.2 mg to semaglutide 2.4 mg (Wegovy) and placebo in more than 1400 adults with obesity and without type 2 diabetes (T2D)
We coordinate with your other healthcare providers to ensure safe, integrated care
Understanding When to Seek Additional Medical Advice While semaglutide is effective for many individuals, its important to recognize when additional medical input is necessary